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Type VII collagen is synthesized and secreted by both
human keratinocytes and ¢broblasts. Although both
cell types can secrete type VII collagen, it is thought
that keratinocytes account for type VII collagen at the
dermal^epidermal junction (DEJ). In this study, we ex-
amined if type VII collagen secreted solely by dermal
¢broblasts could be transported to the DEJ. We estab-
lished organotypic, skin-equivalent cultures composed
of keratinocytes from patients with recessive dystrophic
epidermolysis bullosa (RDEB) and normal dermal ¢-
broblasts. Immuno-labeling of skin equivalent sections
with the anti-type VII collagen antibody revealed tight
linear staining at the DEJ. RDEB ¢broblasts, were
gene-corrected to make type VII collagen and used to
regenerate human skin on immune-de¢cient mice. The
human skin generated by gene-corrected RDEB ¢bro-
blasts or normal human ¢broblasts combined with
RDEB keratinocytes restored type VII collagen expres-
sion at the DEJ in vivo. Further, intradermal injection of
normal human or gene-corrected RDEB ¢broblasts
into mouse skin resulted in the stable expression of
human type VII collagen at the mouse DEJ. These data
demonstrate that human dermal ¢broblasts alone are
capable of producing type VII collagen at the DEJ,
and it is possible to restore type VII collagen gene
expression in RDEB skin in vivo by direct intradermal
injection of ¢broblasts. J Invest Dermatol 121:1021 ^1028,
2003
T
ypeVII collagen is a skin-speci¢c collagen within the
basement membrane zone (BMZ) lying between the
epidermis and dermis of human skin (Burgeson,
1993). It is the major component of anchoring ¢brils,
attachment structures in the BMZ that play a major
role in epidermal^dermal adherence (Briggaman and Wheeler,
1975; Sakai et al, 1986; Lunstrum et al, 1987). Genetic defects in
the type VII collagen gene, designated COL7A1, result in dys-
trophic epidermolysis bullosa (DEB) (Uitto and Christiano,
1992, 1994). DEB is a group of heritable mechanobullous skin dis-
eases characterized by skin fragility, separation of the epidermis
from the dermis (blister formation), milia, and scarring (Lin and
Carter, 1992). The BMZ of patients with DEB is characterized
by a paucity or diminutive size of anchoring ¢brils (Briggaman
andWheeler, 1975). The type VII collagen gene has been cloned,
and genetic linkage studies have identi¢ed the human COL7A1 as
the gene responsible for DEB (Parente et al, 1991; Hovnanian et al,
1992; Ryynanen et al, 1992a; Uitto and Christiano, 1992; Christiano
et al, 1994).
There are several recent studies related to gene therapy for
DEB. Oritz-Urda et al (2002) have recently used a phi C31 inte-
grase-based nonviral gene transfer approach to stably integrate
the COL7A1 cDNA into the genome of primary epidermal pro-
genitor cells from recessive dystrophic epidermolysis bullosa
(RDEB) patients. These investigators demonstrated that gene-
correction could reverse hallmark RDEB features (type VII
collagen protein expression, anchoring ¢bril formation, and
dermal^epidermal cohesion) in regenerated skin tissue trans-
planted onto severe combined immunode¢cient (SCID) mice.
We have developed a minimal lentiviral vector to express type
VII collagen in RDEB keratinocytes and ¢broblasts (in which
type VII collagen was absent) and demonstrated a reversion of
the RDEB cellular phenotype in vitro (Chen et al, 2002). Further,
we used these gene-corrected RDEB cells to create a composite
human skin equivalent transplanted onto SCID mice. The trans-
planted human skin exhibited a restoration of type VII collagen
and anchoring ¢brils at the dermal^epidermal junction (DEJ).
We and others have shown that human keratinocytes and
¢broblasts are capable of synthesizing and secreting type VII
collagen within the DEJ of human skin (Stanley et al, 1985;
Woodley et al, 1985; Ryynanen et al, 1992b). Cells secrete type VII
collagen a chains into the extracellular space where they are pro-
cessed into anchoring ¢brils. Although both cell types can secrete
type VII collagen, it is thought that keratinocytes account for the
majority of typeVII collagen at the DEJ in human skin (Regauer
et al, 1990).
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One reproducible organotypic culture system capable of gener-
ating anchoring ¢brils in vitro is the one developed by Advanced
Tissue Sciences (San Diego, CA; Contard et al, 1993). This culture
system consists of a mesh of synthetic suture material seeded with
human dermal ¢broblasts which generate a dermal equivalent
after 1 mo in culture. Human keratinocytes are then seeded on
the dermal equivalent and allowed to attach and spread. Like the
de-epidermized acellular dermis model of Prunieras and cowor-
kers (1983), the mesh dermal equivalent can be seeded with hu-
man keratinocytes, raised to an air^£uid interface, and used to
create an in vitro human skin equivalent.This model has been used
to examine the formation of a new BMZ between the cultured
keratinocytes and the dermal equivalent (Contard et al, 1993).
Anchoring ¢brils are readily visualized within the BMZ of this
organotypic culture. In addition to studying the BMZ structure
in vitro, the three-dimensional skin model allowed us to evaluate
the contribution of epidermal keratinocytes and dermal ¢bro-
blasts to the type VII collagen found at the BMZ.
In this study, we investigated whether or not type VII collagen
secreted solely by dermal ¢broblasts could be transported to the
DEJ to form a linear BMZ structure. To answer this question, we
took three independent approaches. First, we established organo-
typic skin equivalent cultures composed of keratinocytes from
patients with RDEB and normal dermal ¢broblasts.We showed
that dermal ¢broblasts alone are capable of providing type VII
collagen to the BMZ in vitro. Second, to con¢rm these in vitro
results, we used normal or gene-corrected RDEB ¢broblasts
and parental RDEB keratinocytes to create a composite human
skin equivalent transplanted onto SCID mice. Third, we directly
intradermally injected normal or gene-corrected RDEB ¢bro-
blasts into mouse skin and then examined the mouse skin for
the expression of human type VII collagen at the BMZ. Like the
in vitro results, our data demonstrated that gene-corrected RDEB
¢broblasts and normal human ¢broblasts alone could restore type
VII collagen expression at the BMZ in vivo. All animal studies
were conducted using protocols approved by the University of
Southern California Institutional Animal Use Committee.
MATERIALS AND METHODS
Cell culture The human embryonic kidney cell line 293 Twas cultured
in Dulbecco’s modi¢ed essential medium (DMEM) supplemented with
10% fetal bovine serum. Primary and immortalized RDEB keratinocytes
(gift of S. Herron, Stanford University, Palo Alto, CA) were cultured in
low-calcium, serum-free keratinocyte growth medium supplemented
with bovine pituitary extract and epidermal growth factor (serum-free
keratinocyte growth medium, Gibco BRL, Gaithersburg, MD) as
described by Boyce and Ham (1983) and modi¢ed by O’Keefe and Chiu
(1988). RDEB keratinocytes were immortalized using the E6 and E7
genes of human papillomavirus type 6 as described (Halbert et al, 1992).
Primary RDEB ¢broblasts (gift of S. Herron, Stanford University) were
cultured in DMEM/Ham’s F-12 (1/1) supplemented with 10% fetal bovine
serum.
RDEB patients and cells Patients with RDEB (de¢ned by clinical,
immunohistologic, and ultrastructural criteria) were selected from the
National Epidermolysis Bullosa Registry site at Stanford University.
Lentiviral vector production and gene transfer Lentivirus vector
preparations were produced by three-plasmid transient cotransfection of
human 293 T cells as described previously (Sakoda et al, 1999; Chen et al,
2002). For lentiviral infection, ¢broblast cultures were trypsinized and
seeded onto 60-mm plates and incubated for 24 h. Viral supernatant
(multiplicity of infection of between 5 and 10) was supplemented with 8
mg per mL polybrene and added to cultures which were 30% to 40%
con£uent. Plates were then incubated in a 371C incubator. After 6 h, viral
supernatant was removed, and the cells were washed twice. Cultures were
then incubated in DMEM/F-12 supplemented with 10% fetal bovine
serum.
Protein analysis For immunoblot analysis, normal human dermal
¢broblasts, RDEB ¢broblasts, and lentivirus-transduced RDEB ¢bro-
blasts were grown to con£uence, the medium was changed to serum-free
medium containing 150 mm of ascorbic acid, and the cultures were
maintained for an additional 24 h. The media were collected; equilibrated
to 5 mM EDTA, 50 mM N-ethylmaleimide, and 50 mM phenylmethyl-
sulfonyl £uoride; concentrated 10- to 15-fold (Centricon-100, Amicon,
Beverly, MA); and subjected to 6% SDS^PAGE. Proteins were
electrotransferred onto a nitrocellulose membrane. The presence of type
VII collagen was detected by western blot analysis using a polyclonal
antibody to the NC1 domain of type VII collagen (Chen et al, 1997b).
In vitro organotypic coculture skin model Establishment of an
in vitro skin coculture model was performed as previously described
(Contard et al, 1993). Brie£y, 2106 normal human ¢broblasts were
seeded onto 1.51.5-cm nylon mesh and allowed to grow in DMEM
and generate extracellular matrix components for up to 4 to 6 wk in the
nylon mesh. The ¢broblasts within the nylon mesh transform it into a
‘‘dermal equivalent.’’ A total of 2106 human keratinocytes were then
seeded onto the dermal equivalent and grown in combined medium
(serum-free keratinocyte growth medium:DMEM in a 60:40 ratio with
10% fetal bovine serum) as described (Krueger and Jorgensen, 1997). The
three-dimensional cultures remained submerged for 2 wk after which the
cultures were raised to an air^£uid interface for an additional 1 to 4 weeks.
At the end of the culture period, the cultures were processed for
hematoxylin and eosin light microscopy and immuno£uorescence staining.
Grafting the cell-sorted skin equivalent (CeSSE) onto SCID
mice Reconstitution of human skin on SCID mice by CeSSE was
performed as previously described (Wang et al, 2000) with all studies
conducted by protocols approved by the University of Southern
California Institutional Animal Care and Use Committee (IACUC).
Brie£y, ¢broblasts and keratinocytes were harvested from culture by
trypsinization, neutralized with phosphate-bu¡ered saline (PBS)/10% fetal
bovine serum, and resuspended in serum-free keratinocyte growth
medium. Silicone chambers implanted on the backs of SCID mice were
used as in vivo chambers for the development of a reconstituted human
skin equivalent. Human skin reconstitutions were initiated by adding a
mixed slurry of 6106 keratinocytes and 6106 to 8106 ¢broblasts to
an implanted chamber attached directly onto the mouse muscle fascia.
After 2 wk of transplantation, the skin equivalents were biopsied for
hematoxylin and eosin and immuno£uorescence staining.
Intradermal injection of ¢broblasts into mice Cultured human
¢broblasts were injected as a suspension into the dermis of 4- to 6-wk-
old nude athymic mice (The Jackson Laboratory, Bar Harbor, ME). Gene-
corrected RDEB ¢broblasts, parental RDEB ¢broblasts, and normal
human dermal ¢broblasts (passages 2^5) were used. We injected 5106
cells suspended in 150 mL of PBS into the dorsal back skin of the animals
using a 30-gauge needle. Two to sixteen weeks after injection, mouse skin
biopsies were obtained and subjected to immunostaining using antibody
speci¢c for human type VII collagen (clone LH 7.2; Sigma) as described
below.
Immuno£uorescence staining of cells RDEB or normal human cells
were plated in TissueTek chamber slides (Nunc, Inc., Naperville, IL) on
polylysine at 371C for 18 h. Cells were immersed in periodate^lysine^
paraformaldehyde ¢xative for 10 min at room temperature, washed several
times with PBS to remove ¢xative, and then permeabilized and blocked by
incubating in PBS with 3% bovine serum albumin, 1% saponin, and 10%
normal goat serum for 15 min at room temperature. The cells were
incubated with an a⁄nity-puri¢ed polyclonal antibody to the NC1
domain of type VII collagen (Chen et al, 1997b) at a dilution of 1:200 in a
humidi¢ed chamber for 2 h, washed three times with PBS and 1%
saponin, counterstained with a £uorescein isothiocyanate-conjugated goat
antibody to rabbit IgG (1:200 dilution) for 1 h (Organon Teknika-Capel),
and washed again. The cells were examined and photographed with a
Zeiss microscope equipped with an epiluminating £uorescent light source.
Immuno£uorescence staining of tissue Five-micrometer-thick sect-
ions from the OCT-embedded tissues were cut in a cryostat, ¢xed for 5
min in cold acetone, and air-dried. Sections from CeSSE or mouse skin
intradermally injected with ¢broblasts were incubated with a monoclonal
antibody against human type VII collagen (clone LH 7.2; Sigma) or a
monoclonal antibody against human laminin 5 (P3E4; Santa Cruz
Biotechnology Inc.) followed by a £uorescein isothiocyanate-conjugated
goat anti-mouse IgG. Working dilutions were 1:50 for the primary
antibody and 1:40 for the secondary antibody. Immunolabeling of the
tissue was performed using standard immuno£uorescence methods as
described previously (Gammon et al, 1984).
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RESULTS
Dermal ¢broblasts alone can produce type VII collagen at
the DEJ in vitro To examine whether type VII collagen
secreted solely by dermal ¢broblasts could be transported to the
DEJ to form a linear BMZ structure, we established organotypic
skin-equivalent cultures composed of keratinocytes from patients
with RDEB (in which typeVII collagen was absent) and normal
human dermal ¢broblasts. As shown in Fig 1, Western blot
analysis of the secreted proteins detected the expression of 290-
kDa type VII collagen in conditioned medium from normal
human ¢broblasts and keratinocytes (Fig 1A, lanes 3 and 4). This
band was completely absent in RDEB keratinocytes and RDEB
¢broblasts (Fig 1A, lanes 1 and 2). Further, normal human
keratinocytes expressed signi¢cantly higher levels of type VII
collagen than normal human ¢broblasts (compare lane 4 to lane 3).
Figure 1(B) shows the immuno£uorescence staining of the above
cells using an a⁄nity-puri¢ed antibody to the NC1 domain of
type VII collagen. Both normal human keratinocytes and
normal human ¢broblasts display uniformly detectable type VII
collagen protein. As expected, there is no immunostaining of the
parental RDEB keratinocytes or RDEB ¢broblasts.
To determine whether dermal ¢broblasts alone can contribute
to type VII collagen expression in DEJ, we constructed an in vitro
three-dimensional skin model using keratinocytes and ¢broblasts
as described previously (Contard et al, 1993). Ten-micrometer
vertical sections of the organotypic cocultures were subjected to
immuno£uorescent labeling using an a⁄nity-puri¢ed polyclonal
antibody to the NC1 domain of type VII collagen. As shown in
Fig 2, after 4 wk of culture at an air interface, immunolabeling of
cocultures of normal human ¢broblasts and RDEB keratinocytes
revealed tight linear staining at the DEJ between the
keratinocytes and dermal equivalent (Fig 2A). This pattern was
identical to cultures composed of normal control cells
(Fig 2D). In contrast, the cocultures composed of RDEB
keratinocytes and RDEB ¢broblasts did not generate type VII
collagen (Fig 2C). There was no DEJ staining in the negative
control specimens stained with normal rabbit serum (Fig 2B,E).
We conclude that dermal ¢broblasts alone are capable of
producing type VII (anchoring ¢bril) collagen at the DEJ in vitro.
Gene-corrected ¢broblasts alone can produce type VII
collagen at the DEJ in vivo We have previously used a
minimal lentiviral vector to express type VII collagen in RDEB
keratinocytes and ¢broblasts (Chen et al, 2002). These gene-
corrected cells were then used to regenerate human skin on
immune-de¢cient mice using a CeSSE model. We showed that
gene-corrected RDEB keratinocytes alone could restore type
VII collagen expression and anchoring ¢bril formation at the
DEJ in vivo. To determine whether gene-corrected RDEB
¢broblasts alone could also produce type VII collagen at DEJ
in vivo, we reconstituted human skin under in vivo conditions by
the infusion of a mixed-cell slurry of keratinocytes and dermal
¢broblasts into an inert implanted silicone chamber grafted onto
SCID mice as described previously (Wang et al, 2000). Figure
3(A) shows the Western blot analysis of the proteins secreted
from the conditioned medium of ¢broblasts used for this study.
The expression of 290-kDa type VII collagen was detected in
both normal human ¢broblasts (lane 2) and gene-corrected
RDEB ¢broblasts (lane 3). This band was completely absent in
parental RDEB ¢broblasts (lane 1). Gene-corrected RDEB
¢broblasts expressed levels of type VII collagen protein that are
comparatively higher than levels in normal ¢broblasts (compare
lanes 2 and 3).
Gene transfer e⁄ciency in vitro was 495% as measured by
immuno£uorescence staining of lentivirus-transduced RDEB
¢broblasts using an a⁄nity puri¢ed antibody to the NC1
domain of type VII collagen (Fig 3B, RDEB/FB/C7). There was
no evidence of type VII collagen expression in the parental
RDEB ¢broblasts (Fig 3B, RDEB/FB).
Gene-corrected and parental RDEB cells, along with normal
control cells, were used to generate human skin tissue on SCID
mice. Two weeks after cell sorting, the mixed-cell slurry
organized into an epidermis and a dermis separated by a well-
formed BMZ. The regenerated human skin tissue specimens
were then immunolabeled against monoclonal antibody LH 7.2,
which only recognizes human type VII collagen. As shown
in Fig 4, skin equivalents composed of parental RDEB
keratinocytes combined with gene-corrected RDEB ¢broblasts
(Fig 4B) or normal human ¢broblasts (Fig 4C) expressed type
VII collagen at the BMZ location, in a pattern similar to normal
control cells (Fig 4D). In contrast, the parental RDEB cells
generated human skin devoid of type VII collagen expression
(Fig 4A). The human-speci¢c origin and the expression of
another BMZ component were con¢rmed by immunostaining
with antibodies speci¢c for human laminin 5 (Fig 4E^H).
Figure1. Expression of typeVII collagen in cultured cells used for skin model. (A) Conditioned media from RDEB keratinocytes (lane 1), RDEB
¢broblasts (lane 2), normal human ¢broblasts (lane 3), and normal human keratinocytes (lane 4) were concentrated and subjected to 6% SDS^PAGE fol-
lowed by immunoblot analysis using a polyclonal antibody to either NC1 or MMP-2. MMP2 was included as an internal control of protein quality and
loading.The position of full-length 290-kDa typeVII collagen is indicated. (B) Immunohistochemistry with an a⁄nity-puri¢ed polyclonal antibody to the
NC1 domain of type VII collagen. RDEB/KC, parental RDEB keratinocytes; RDEB/FB, parental RDEB ¢broblasts; HKC, normal human keratinocytes;
NFB, normal human ¢broblasts.
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TypeVII collagen is the major component of anchoring ¢brils,
structures that anchor the epidermis to the underlying dermis.
RDEB is characterized by a reduced or complete absence of
anchoring ¢brils in the patients’ skin. To determine whether
gene-corrected RDEB ¢broblasts alone could restore anchoring
¢brils at the BMZ in vivo, transmission electron microscopy was
performed on the skin regenerated from gene-corrected RDEB
¢broblasts combined with parental RDEB keratinocytes. As
shown in Fig 5, the regenerated skin equivalent had an
epidermis and dermis separated by a well-formed neo-BMZ.
This neo-BMZ exhibited hemidesmosomes, a lamina lucida, a
lamina densa, and numerous anchoring ¢brils. The anchoring
¢brils are wheat-stack-shaped structures that emanate down
perpendicularly from the lamina densa into the papillary dermis.
In contrast, skin equivalent generated from parent RDEB cells
entirely lacked anchoring ¢brils (data not shown). These data
demonstrate that type VII collagen derived solely from dermal
¢broblasts can restore type VII collagen expression and
anchoring ¢bril formation at the BMZ in vivo.
Injection of gene-corrected RDEB ¢broblasts can synthesize
and deposit human typeVII collagen at the mouse DEJ To
test the feasibility of using gene-corrected RDEB ¢broblasts to
synthesize and deposit type VII collagen in skin, we injected
cultured gene-corrected ¢broblasts from RDEB patients or
normal human dermal ¢broblasts intradermally into the skin of
nude athymic mice. Skin biopsies were obtained every week after
the cell injection and subjected to immunostaining with an
antibody speci¢c for human type VII collagen. As shown in
Fig 6A, 2 wk after the intradermal injection of the cells, the
gene-corrected RDEB ¢broblasts deposited human type VII
collagen within the mouse’s skin (Fig 6A). Further, the human-
derived typeVII collagen localized to the DEJ of the animal’s skin
in a tight linear band. This result was identical to those
experiments in which normal human dermal ¢broblasts were
injected intradermally into nude mice (Fig 6B). As expected,
when the mice were injected intradermally with parental
RDEB ¢broblasts, the mouse’s skin and DEJ entirely lacked type
VII collagen expression (Fig 6A, panel C).We wished to con¢rm
that the localization of the human type VII collagen was truly
located at the BMZ of the mouse’s skin. Therefore, we colabeled
the same vertical frozen sections of mouse skin with a polyclonal
antibody that recognizes both mouse and human type VII
collagen (Fig 6A, panels D^F). The results of coimmunolabeling
the mice skin with these two antibodies show perfect
colocalization in the mouse’s BMZ when the images are merged
(Fig 6A, panels G^I).
The expression of human type VII collagen by gene-corrected
RDEB ¢broblasts was sustained for at least 4 mo in the mouse
DEJ after a single intradermal injection of gene-corrected
RDEB ¢broblasts (Fig 6B, panels A^C). Further, there is stable
retention of the injected type VII collagen-expressing gene-
corrected RDEB ¢broblasts in the dermal tissue at all time
points (Fig 6B, panels D^F). Similar results were obtained in the
mice skin injected with normal human ¢broblasts (data not
shown).
DISCUSSION
This study demonstrates that dermal ¢broblasts alone are capable
of synthesizing and depositing type VII collagen at the BMZ ly-
ing between the epidermis and dermis. These results are surpris-
ing because epidermal keratinocytes were previously thought to
be the major contributor of type VII collagen at the BMZ.
Nevertheless, our data from a purely human system are in accor-
dance with the results of Marinkovich et al (1993), who showed
Figure 2. Immuno£uorescence staining of
cocultures with antibody to type VII col-
lagen. Cocultures 4 wk after being raised to
the air^£uid interface were snap-frozen in li-
quid nitrogen and embedded in OCT, and 10-
mm sections were cut. The sections were sub-
jected to immuno£uorescent labeling using an
a⁄nity-puri¢ed polyclonal antibody to the
NC1 domain of type VII collagen (A,C,D,F)
and normal rabbit serum (B,E). (A,B) Cocul-
tures composed of normal human ¢broblasts
combined with parent RDEB keratinocytes.
(D,E) Cocultures composed of normal human
¢broblasts combined with normal human kera-
tinocytes. (C) Cocultures composed of parental
RDEB keratinocytes and RDEB ¢broblasts. F,
normal human skin.
Figure 3. Expression of type VII collagen in the cultured cells used
for CeSSE skin model. (A) Immunoblot analysis of proteins from con-
ditioned media of parental RDEB ¢broblasts (lane 1), normal human ¢bro-
blasts (lane 2), and gene-corrected RDEB ¢broblasts (lane 3). MMP2 was
included as an internal control of protein quality and loading.The position
of the full-length 290-kDa type VII collagen is indicated. (B) Immunohis-
tochemistry with an a⁄nity-puri¢ed polyclonal antibody to the NC1
domain of typeVII collagen. Note the very high e⁄ciency of typeVII col-
lagen gene transfer to RDEB cells, which, in their native state, cannot
express type VII collagen. RDEB/FB, parental RDEB ¢broblasts; RDEB/
FB/C7, RDEB ¢broblasts transduced with lentiviral expression vector for
typeVII collagen.
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that human dermal ¢broblasts could contribute typeVII collagen
to the BMZ of a composite dual-species cultures consisting of
human dermal ¢broblasts and bovine keratinocytes in vitro.
Our studies show that type VII collagen produced by dermal
¢broblasts can organize into a tight linear BMZ component.
One does not observe type VII collagen within and throughout
the dermal equivalent. Rather, it is localized to the BMZ be-
tween the dermal equivalent and epidermis. How this process oc-
curs is not clear. Nevertheless, we and others have shown that
typeVII collagen has great a⁄nity for laminin-5 and type IV col-
lagen within the BMZ (Champlioaud et al, 1996; Chen et al, 1997a,
1999).We believe that the dermal-¢broblast-derived type VII col-
lagen within the dermal equivalent reaches the epithelial interface
by di¡usion and selectively adheres to the BMZ. It concentrates
there within these cultures because it adheres to the laminin-5
and type IV collagen produced and deposited by the RDEB ker-
atinocytes (Chen et al, 1997b, 1999).
DEB is an incurable, potentially fatal, skin disease for which
gene therapy may hold considerable promise. The absence of type
VII collagen expression and a paucity of anchoring ¢brils in DEB
cause skin fragility, blistering, and scarring after mild trauma.
One strategy for gene therapy would be to deliver a typeVII col-
lagen expression vector into skin cells by ex vivo gene therapy.The
skin cells in tissue culture would be selected for only those cells
that are gene-corrected and express type VII collagen. These cul-
ture autografts would then be transplanted onto the a¡ected areas
of DEB patients.
We and others have shown that gene-corrected keratinocytes
alone can be used to restore type VII collagen expression and an-
choring ¢bril formation in vivo (Chen et al, 2002; Oritz-Urda
et al, 2002). Although grafting gene-corrected epidermal auto-
grafts onto RDEB patients is feasible, the procedure has some
technical problems. The degree of autograft take has been a con-
cern, because many of the cultured autografts transplanted onto
burn wounds may be lost if the patient is not immobilized well
and the bandages move. Also, the grafting procedure requires sur-
gical excision of the patient’s skin down to fascia for optimal
autograft take (Gallico et al, 1984; Herzog et al, 1988; Woodley et
al, 1988).
Our data indicate that in vivo long-term, stable production of
human type VII collagen can be achieved by direct application of
¢broblast-mediated gene transfer. Because ¢broblasts can be pas-
saged 20 to 30 times in vitro, are easy to grow in larger numbers,
and can be frozen in stocks available for thawing and regrowth
(Krueger, 2000), it is conceivable that dermal ¢broblasts from
RDEB patients could be gene-corrected and then injected high
in the papillary dermis of the patient’s own skin, similar to inject-
ing bovine collagen for wrinkles. The gene-corrected ¢broblasts,
high within the papillary dermis, would then secrete type VII
collagen into the extracellular space. Once in the extracellular
space of the papillary dermis, the secreted type VII collagen
would selectively concentrate at the BMZ and provide the needed
epidermal^dermal adherence that is lacking in RDEB patients. In
this regard, a very recent study showed that intradermal injection
of RDEB ¢broblasts overexpressing typeVII collagen into intact
RDEB skin transplanted onto SCID mice stably restored type
VII collagen expression in vivo (Oritz-Urda et al, 2003). This
expression normalized many of the key features of the trans-
planted RDEB skin when cells were used that ‘‘overexpress’’ type
VII collagen. The injection of normal dermal ¢broblasts was
incapable of restoring type VII collagen at the DEJ.
Our in vitro and in vivo experiments described herein are largely
in accordance with those of Oritz-Urda et al (2003). Nevertheless,
we ¢nd that normal human ¢broblasts are capable of secreting
and depositing type VII collagen at the DEJ as e¡ectively as
Figure 4. Restoration of typeVII collagen to reconstituted DEB skin in vivo. Immuno£uorescence staining of reconstituted DEB and control skin
grafts was performed with antibodies speci¢c for human type VII collagen (A^D) and laminin 5 (E^H). (A,E) Tissue reconstituted from parental RDEB
keratinocytes and RDEB ¢broblasts. (B,F) Tissue reconstituted from parental RDEB keratinocytes and gene-corrected RDEB ¢broblasts. (C,G) Tissue
reconstituted from parental RDEB keratinocytes and normal human ¢broblasts. (D,H) Normal control tissue reconstituted from normal human epidermal
keratinocytes and normal human dermal ¢broblasts. Bars, 200 mm. e, epidermis; d, dermis.
Figure 5. Restoration of anchoring ¢brils to reconstituted DEB skin
in vivo.Transmission electron microscopy was performed on skin regener-
ated from gene-corrected RDEB ¢broblasts with parent RDEB keratino-
cytes. Restored anchoring ¢brils (AF) measuring 200 nm or more are
labeled with arrows in the BMZ. The BMZ also has a well formed lamina
lucida (LL), lamina densa (LD), and hemidesmosome (HD). Bars, 200 nm.
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gene-corrected RDEB ¢broblasts. This was true in both the
in vitro three-dimensional skin coculture model and the in vivo
cell-sorted skin equivalent model. Further, our experiments with
the intradermal injection of either gene-corrected RDEB ¢bro-
blasts or normal human ¢broblasts into intact mouse skin also
generated correctly localized human typeVII collagen expression
at the mouse DEJ using either cell type. The reasons for the dif-
ference in conclusions are several. It is possible that the number of
¢broblasts used in our in vitro skin coculture system (2106), in
our in vivo CeSSE skin model (6106), and in the intradermal
injection into the mouse skin (5106) is signi¢cantly greater than
that used in their study (106). It is also possible that the age (num-
ber of passages) of ¢broblasts is di¡erent.We have observed that
early-passage ¢broblasts produce much more type VII collagen
than late-passage ¢broblasts in culture. In this regard, we normally
performed our experiments using ¢broblasts from passages 2 to 5.
Human skin cells in culture lose their cell surface HLA pro-
teins and become less immunogenic. In accordance with this no-
tion, allogeneic human skin equivalent cultures (Apligraf) have
been successfully transplanted onto RDEB patient wounds with-
out rejection (Falabela et al, 2000). Nevertheless, this type of cul-
ture is technically di⁄cult to produce and cannot be expanded
like cultured ¢broblasts, which can be grown in large amounts
in roller bottles from just a few cells. Nevertheless, perhaps it
would be possible to inject normal cultured human dermal ¢bro-
blasts intradermally into RDEB patients’ skinwith or without
exogenous immunosuppressive medications. This would obviate
the need for gene correction and allow for large-scale production
of injectable cells able to synthesize and secrete typeVII collagen.
We previously showed that when human keratinocytes and
¢broblasts are mixed as a cell slurry and applied to an immuno-
compromised murine host, the cells sort themselves spontan-
eously into a full-thickness human skin equivalent with a well
formed epidermis and neodermis separated by a BMZ (Wang et
al, 2000). In this study, we applied this model to assess the ability
of gene-corrected RDEB ¢broblasts and parental keratinocytes
Figure 6. Sustained deposition of human
type VII collagen at the mouse DEJ after a
single intradermal injection of ¢broblasts.
(A) Immuno£uorescence staining of mouse skin
intradermally injected with ¢broblasts 2 wk
after injection was performed with either a
monoclonal antibody speci¢c for human type
VII collagen (green, panels A^C) or a rabbit poly-
clonal antibody recognizing both mouse and
human type VII collagen (red, panels D-F).
(A,D,G) Skin injected with gene corrected
RDEB ¢broblasts. (B,E,H) Skin injected with
normal human ¢broblasts. (C,F,I) Skin injected
with parental RDEB ¢broblasts. Merged
images (panels G-I) demonstrate the colocaliza-
tion of human type VII collagen with mouse
type VII collagen in the mouse’s BMZ. (B) Skin
from mice injected intradermally with gene-
corrected RDEB ¢broblasts was stained with a
monoclonal antibody speci¢c for human type
VII collagen. (A,D) Biopsies taken 2 mo after
injection; (B,E) biopsies taken 3 mo after injec-
tion; (C,F) biopsies taken 4 mo after injection. e,
epidermis; d, dermis.
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to restore the expression of type VII collagen at the DEJ. Immu-
nostaining of the reconstituted neo-skin with a human-speci¢c
antibody to typeVII collagen demonstrated a linear band of type
VII collagen at the DEJ in specimens created by gene-corrected
RDEB ¢broblasts or normal human ¢broblasts mixed with
RDEB keratinocytes. In contrast, uncorrected wild-type RDEB
cells produced skin specimens entirely lacking type VII collagen.
Although lentiviral-vector-transduced RDEB ¢broblasts express
higher quantities of type VII collagen than normal human ¢bro-
blasts, we did not observe signi¢cant di¡erences in the type VII
collagen staining at the BMZ of the skin generated from either
gene-corrected RDEB ¢broblasts or normal human ¢broblasts.
Because type VII collagen interacts within other BMZ compo-
nents such as laminin-5 and type IV collagen (Champliaud et al,
1996; Chen et al, 1997a, 1999), it is possible that the amount of type
VII collagen deposited at the BMZ is limited by the amount of
other available BMZ components to which type VII collagen ad-
heres, such as laminin-5 and type IV collagen, which are pro-
duced in limited quantities.
One concern with the use of lentiviral vectors in humans is
that these contain HIV-derived components. Nevertheless, the
virulence genes env, vif, vpr, vpu, nef, and tat have been completely
deleted from the third-generation vector systems (Zu¡erey et al,
1997; Dull et al, 1998). Here, we have utilized an even more atte-
nuated minimal lentivirus vector for stable gene transfer to
human dermal ¢broblasts. One important feature of this minimal
transfer vector design is the further reduction of HIV-derived
sequences, from the 1 to 2 kb retained in third-generation vectors
to only 774 nucleotides in the new minimal vector. Removal of
these sequences not only further improves the safety pro¢le, but
also increases the cloning capacity of the vector, such that the
9-kb gene encoding type VII collagen could be accommodated.
The new minimal lentiviral vector is also designed with a 30 end
LTR promoter that has been self-inactivated. Therefore, if it
integrates into the host genomic DNA, it cannot drive expression
of the downstream cellular genes.We have injected over 50 mice
with human cells transduced with this new fourth-generation
minimal vector, and none of the mice have developed tumors or
demonstrated an altered phenotype or survival.We normally in-
fect RDEB ¢broblasts with the new minimal lentiviral vector
encoding for type VII collagen at multiplicities of infection of
between 5 and 10. Under these conditions, the average number
of integration events in the transduced cells is between 1 and 3
copy numbers per cell.We believe that it is unlikely for genomic
instability to occur using lentiviral infection with such a low
multiplicity of infection.
In summary, our studies demonstrate that either normal human
¢broblasts or gene-corrected RDEB ¢broblasts alone are capable of
synthesizing and depositing typeVII collagen in the DEJ in a three-
dimensional skin coculture model in vitro, in a human skin/mouse
xenograft model in vivo, and in an intradermal injection into an in-
tact mouse skin model.Thus, our data may provide a basis for ther-
apeutic gene transfer in human DEB using ¢broblasts only and
o¡er a rational and generally applicable approach for developing fu-
ture ex vivo genetic therapies to correct dermatologic disorders asso-
ciated with defects in secreted matrix proteins.
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